The aim of the present study was to evaluate the expression of receptors for luteinizing hormone-releasing hormone (LHRH) in human specimens of triple-negative breast cancers (TNBC). In addition, we used in vitro and in vivo models of TNBC to investigate if these receptors are suitable targets for the treatment with the LHRH antagonist cetrorelix ...
Buchholz S +13 more
openaire +4 more sources
Luteinizing Hormone-Releasing Hormone (LHRH)-Targeted Treatment in Ovarian Cancer. [PDF]
Nayak P +5 more
europepmc +1 more source
Radiolabeled LHRH and FSH Analogues as Cancer Theranostic Agents: A Systematic Review. [PDF]
Giorgio A +4 more
europepmc +1 more source
Two cases of MACS due to PBMAH associated with an in vivo aberrant response to LHRH treated with leuprolide acetate. [PDF]
Branchaud-Croisetière L +2 more
europepmc +1 more source
The Involvement of the Peptidergic Systems in Breast Cancer Development. [PDF]
Sánchez ML +5 more
europepmc +1 more source
Clinical and genetic predictors of persistent chemotherapy-induced alopecia despite scalp cooling in breast cancer. [PDF]
Lee H +8 more
europepmc +1 more source
Advancements in Polysaccharide-Based Nanoparticles for the Treatment of Breast Cancer: A Comprehensive Review. [PDF]
Mohanto S +6 more
europepmc +1 more source
A stepwise responsive Au-SS-PEG/Sor/ATP<sub>aptamer</sub>/LHRH-MPG<sup>ΔNLS</sup> drug delivery vector system for overcoming drug resistance in immunotherapy of hepatocellular carcinoma. [PDF]
Tong M +5 more
europepmc +1 more source
The Double-Edged Nature of the Gonadotropin-Releasing Hormone Agonist (GnRHa) Long Protocol: A Case of Paradoxical Ovarian Hyperstimulation During the Expected Downregulation Phase. [PDF]
Nádasdi B +5 more
europepmc +1 more source
Menopause-related side effects in HR+ early breast cancer: insights from clinical practice. [PDF]
Dimitrijevic M +5 more
europepmc +1 more source

